Keywords: canada, approves, oncolytics, reolysin, trial, biotech, received

Canada approves Oncolytics' Reolysin trial

Article | 12 October 2001

Oncolytics Biotech has received approval from Health Canada to initiatea clinical trial to evaluate the efficacy of intratumoral administration of ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Drugs

Amino Acids

Injection

Physostigmine Salicylate

Go to drug listing